RNA-seq analysis revealed downregulation of the MAPK/ERK pathway through the downstream effectors ICAM1, leading to suppress tumor growth and increase chemosensitivity of liver cancer toward chemotherapy [52]. Here, MAPK1 is linked to liver cancer.